IHS Chemical Week

World News and Views :: Projects

DSM Divests Biologics Plant; Focuses on Cell Technology

1:20 PM MDT | June 13, 2007 | Alex Scott

DSM says it has sold its biologic drugs plant at Montreal to AstraZeneca for an undisclosed sum. The Montreal facility was DSM’s only commercial manufacturing plant for biologic drugs. The company says it plans to focus its biologics activities on developing manufacturing technologies and services. Staal: Change of strategy for biologics. DSM says it mothballed the Montreal plant in December 2005 due to a lack of orders for products from the facility. DSM says it will book a “small profit” from the divestment but it declined to provide...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa